Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Cohen

Showing results (21-30 of 402) with videos related to

Pageof 41
Sort By:
The Journal of Invasive Cardiology|March 6, 2015
Where are we with vascular closure devices after percutaneous arteriotomy?Marc Cohen
The American Journal of Medicine|January 28, 2010
The thrombin hypothesis in ACS: a disappointing disconnect between bench data and bedside clinical trialsMarc Cohen
Policy Brief (Center for Home Care Policy and Research (U.S.))|March 6, 2004
The impact of private long-term care insurance on claimants: formal and informal care in the communityMarc Cohen, Jessica Miller
Journal of Alternative and Complementary Medicine (New York, N.Y.)|March 5, 2008
Investigating the claims of Konstantin Buteyko, M.D., Ph.D.: the relationship of breath holding time to end tidal CO2 and other proposed measures of dysfunctional breathingRosalba Courtney, Marc Cohen
Policy Brief (Center for Home Care Policy and Research (U.S.))|March 5, 2004
The use of nursing home and assisted living facilities among private long-term care insurance claimants: the experience of disabled eldersMarc Cohen, Jessica Miller
International Journal of Environmental Research and Public Health|July 22, 2011
Assessing diet as a modifiable risk factor for pesticide exposureLiza Oates, Marc Cohen
Cardiovascular Therapeutics|June 5, 2014
The "dual-pathway" strategy after acute coronary syndrome: rivaroxaban and antiplatelet agents in the ATLAS ACS 2-TIMI 51 trialMarc Cohen, Deepa Iyer
Expert Opinion on Pharmacotherapy|April 8, 2011
Enoxaparin: a pharmacologic and clinical reviewZafar Iqbal, Marc Cohen
Evidence-Based Cardiovascular Medicine|March 15, 2006
At six months, enoxaparin is more effective than tinzaparin for people with non ST-segment elevation acute coronary syndromesMarc Cohen, Debbie Singh
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 4, 2021
STEMI in the Age of COVID: Unmasking Our Weaknesses. Is It the Virus That Matters?Marc Cohen, Sumit Sohal
Pageof 41

Showing results (21-30 of 402) with videos related to

Sort By:
Pageof 41
The Journal of Invasive Cardiology|March 6, 2015
Where are we with vascular closure devices after percutaneous arteriotomy?Marc Cohen
The American Journal of Medicine|January 28, 2010
The thrombin hypothesis in ACS: a disappointing disconnect between bench data and bedside clinical trialsMarc Cohen
Policy Brief (Center for Home Care Policy and Research (U.S.))|March 6, 2004
The impact of private long-term care insurance on claimants: formal and informal care in the communityMarc Cohen, Jessica Miller
Journal of Alternative and Complementary Medicine (New York, N.Y.)|March 5, 2008
Investigating the claims of Konstantin Buteyko, M.D., Ph.D.: the relationship of breath holding time to end tidal CO2 and other proposed measures of dysfunctional breathingRosalba Courtney, Marc Cohen
Policy Brief (Center for Home Care Policy and Research (U.S.))|March 5, 2004
The use of nursing home and assisted living facilities among private long-term care insurance claimants: the experience of disabled eldersMarc Cohen, Jessica Miller
International Journal of Environmental Research and Public Health|July 22, 2011
Assessing diet as a modifiable risk factor for pesticide exposureLiza Oates, Marc Cohen
Cardiovascular Therapeutics|June 5, 2014
The "dual-pathway" strategy after acute coronary syndrome: rivaroxaban and antiplatelet agents in the ATLAS ACS 2-TIMI 51 trialMarc Cohen, Deepa Iyer
Expert Opinion on Pharmacotherapy|April 8, 2011
Enoxaparin: a pharmacologic and clinical reviewZafar Iqbal, Marc Cohen
Evidence-Based Cardiovascular Medicine|March 15, 2006
At six months, enoxaparin is more effective than tinzaparin for people with non ST-segment elevation acute coronary syndromesMarc Cohen, Debbie Singh
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 4, 2021
STEMI in the Age of COVID: Unmasking Our Weaknesses. Is It the Virus That Matters?Marc Cohen, Sumit Sohal
Pageof 41